嶺南股份(002717.SZ):聯合體中標25.33億元唐山全域治水清水潤城縣區工程PPP項目
格隆匯2月19日丨嶺南股份(002717.SZ)公佈,近日,公司子公司嶺南水務集團有限公司收到唐山市政府採購中心發出的《中標通知書》,確定中交第一航務工程局有限公司、嶺南水務集團有限公司、中交河海工程有限公司組成的聯合體為“唐山全域治水清水潤城縣區工程PPP項目社會資本方採購公開招標(Z1302001909721001-2)”的中標人,項目估算總投資約25.33億元,服務期限25年(含建設期3年)。
上述項目估算總投資約佔公司2018年度經審計的營業收入的28.65%,系公司積極發展“大生態”業務,大力拓展公司在華北地區水環境業務的重要成果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.